|
|
| (2 intermediate revisions by 2 users not shown) |
| Line 1: |
Line 1: |
| __NOTOC__ | | __NOTOC__ |
| {{SI}} | | {{Immune Thrombocytopenia}} |
| '''For patient information, click [[Immune Thrombocytopenia (patient information)|here]]''' | | '''For patient information, click [[Immune Thrombocytopenia (patient information)|here]]''' |
|
| |
|
| {{CMG}}; {{AE}} | | {{CMG}}; {{AE}} {{Maryam}} |
|
| |
|
| {{SK}} | | {{SK}} |
| ==Overview==
| |
|
| |
|
| ==Historical Perspective== | | ==[[Immune Thrombocytopenia overview|Overview]]== |
| [Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event]. | |
|
| |
|
| The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
| | ==[[Immune Thrombocytopenia historical perspective|Historical Perspective]]== |
|
| |
|
| In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
| | ==[[Immune Thrombocytopenia classification|Classification]]== |
|
| |
|
| In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
| | ==[[Immune Thrombocytopenia pathophysiology|Pathophysiology]]== |
|
| |
|
| There have been several outbreaks of [disease name], including -----.
| | ==[[Immune Thrombocytopenia causes|Causes]]== |
|
| |
|
| In [year], [diagnostic test/therapy] was developed by [scientist] to treat/diagnose [disease name].
| | ==[[Immune Thrombocytopenia differential diagnosis|Differentiating Immune Thrombocytopenia from other Diseases]]== |
|
| |
|
| ==Classification== | | ==[[Immune Thrombocytopenia epidemiology and demographics|Epidemiology and Demographics]]== |
| There is no established system for the classification of [disease name].
| |
|
| |
|
| OR
| | ==[[Immune Thrombocytopenia risk factors|Risk Factors]]== |
|
| |
|
| [Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4]. | | ==[[Immune Thrombocytopenia screening|Screening]]== |
|
| |
|
| OR
| | ==[[Immune Thrombocytopenia natural history, complications and prognosis|Natural History, Complications and Prognosis]]== |
| | |
| [Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3].
| |
| [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
| |
| | |
| OR
| |
| | |
| Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
| |
| | |
| OR
| |
| | |
| If the staging system involves specific and characteristic findings and features:
| |
| According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
| |
| | |
| OR
| |
| | |
| The staging of [malignancy name] is based on the [staging system].
| |
| | |
| OR
| |
| | |
| There is no established system for the staging of [malignancy name].
| |
| | |
| ==Pathophysiology==
| |
| The exact pathogenesis of [disease name] is not fully understood.
| |
| | |
| OR
| |
| | |
| It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
| |
| | |
| OR
| |
| | |
| [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
| |
| | |
| OR
| |
| | |
| Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
| |
| | |
| OR
| |
| | |
| | |
| [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
| |
| | |
| OR
| |
| | |
| The progression to [disease name] usually involves the [molecular pathway].
| |
| | |
| OR
| |
| | |
| The pathophysiology of [disease/malignancy] depends on the histological subtype.
| |
| | |
| ==Causes==
| |
| Disease name] may be caused by [cause1], [cause2], or [cause3].
| |
| | |
| OR
| |
| | |
| Common causes of [disease] include [cause1], [cause2], and [cause3].
| |
| | |
| OR
| |
| | |
| The most common cause of [disease name] is [cause 1]. Less common causes of [disease name] include [cause 2], [cause 3], and [cause 4].
| |
| | |
| OR
| |
| | |
| The cause of [disease name] has not been identified. To review risk factors for the development of [disease name], click [[Pericarditis causes#Overview|here]].
| |
| | |
| ==Differentiating ((Page name)) from other Diseases==
| |
| [Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
| |
| | |
| OR
| |
| | |
| [Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
| |
| | |
| ==Epidemiology and Demographics==
| |
| The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
| |
| | |
| OR
| |
| | |
| In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
| |
| | |
| OR
| |
| | |
| In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate of [number range]%.
| |
| | |
| | |
| | |
| Patients of all age groups may develop [disease name].
| |
| | |
| OR
| |
| | |
| The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
| |
| | |
| OR
| |
| | |
| [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
| |
| | |
| OR
| |
| | |
| [Chronic disease name] is usually first diagnosed among [age group].
| |
| | |
| OR
| |
| | |
| [Acute disease name] commonly affects [age group].
| |
| | |
| | |
| | |
| There is no racial predilection to [disease name].
| |
| | |
| OR
| |
| | |
| [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
| |
| | |
| | |
| | |
| [Disease name] affects men and women equally.
| |
| | |
| OR
| |
| | |
| [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.
| |
| | |
| | |
| | |
| The majority of [disease name] cases are reported in [geographical region].
| |
| | |
| OR
| |
| | |
| [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
| |
| | |
| ==Risk Factors==
| |
| There are no established risk factors for [disease name].
| |
| | |
| OR
| |
| | |
| The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
| |
| | |
| OR
| |
| | |
| Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
| |
| | |
| OR
| |
| | |
| Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
| |
| | |
| ==Screening==
| |
| There is insufficient evidence to recommend routine screening for [disease/malignancy].
| |
| | |
| OR
| |
| | |
| According to the [guideline name], screening for [disease name] is not recommended.
| |
| | |
| OR
| |
| | |
| According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
| |
| | |
| ==Natural History, Complications, and Prognosis==
| |
| If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
| |
| | |
| OR
| |
| | |
| Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
| |
| | |
| OR
| |
| | |
| Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
| |
|
| |
|
| ==Diagnosis== | | ==Diagnosis== |
| ===Diagnostic Study of Choice===
| | [[Immune Thrombocytopenia diagnostic study of choice|Diagnostic study of choice]] | [[Immune Thrombocytopenia history and symptoms|History and Symptoms]] | [[Immune Thrombocytopenia physical examination|Physical Examination]] | [[Immune Thrombocytopenia laboratory findings|Laboratory Findings]] | [[Immune Thrombocytopenia electrocardiogram|Electrocardiogram]] | [[Immune Thrombocytopenia x ray|X-Ray Findings]] | [[Immune Thrombocytopenia echocardiography and ultrasound|Echocardiography and Ultrasound]] | [[Immune Thrombocytopenia CT scan|CT-Scan Findings]] | [[Immune Thrombocytopenia MRI|MRI Findings]] | [[Immune Thrombocytopenia other imaging findings|Other Imaging Findings]] | [[Immune Thrombocytopenia other diagnostic studies|Other Diagnostic Studies]] |
| The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met: [criterion 1], [criterion 2], [criterion 3], and [criterion 4].
| |
| | |
| OR
| |
| | |
| The diagnosis of [disease name] is based on the [criteria name] criteria, which include [criterion 1], [criterion 2], and [criterion 3].
| |
| | |
| OR
| |
| | |
| The diagnosis of [disease name] is based on the [definition name] definition, which includes [criterion 1], [criterion 2], and [criterion 3].
| |
| | |
| OR
| |
| | |
| There are no established criteria for the diagnosis of [disease name].
| |
| | |
| ===History and Symptoms===
| |
| The majority of patients with [disease name] are asymptomatic.
| |
| | |
| OR
| |
| | |
| The hallmark of [disease name] is [finding]. A positive history of [finding 1] and [finding 2] is suggestive of [disease name]. The most common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3]. Common symptoms of [disease] include [symptom 1], [symptom 2], and [symptom 3]. Less common symptoms of [disease name] include [symptom 1], [symptom 2], and [symptom 3].
| |
| | |
| ===Physical Examination===
| |
| Patients with [disease name] usually appear [general appearance]. Physical examination of patients with [disease name] is usually remarkable for [finding 1], [finding 2], and [finding 3].
| |
| | |
| OR
| |
| | |
| Common physical examination findings of [disease name] include [finding 1], [finding 2], and [finding 3].
| |
| | |
| OR
| |
| | |
| The presence of [finding(s)] on physical examination is diagnostic of [disease name].
| |
| | |
| OR
| |
| | |
| The presence of [finding(s)] on physical examination is highly suggestive of [disease name].
| |
| | |
| ===Laboratory Findings===
| |
| An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
| |
| | |
| OR
| |
| | |
| Laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].
| |
| | |
| OR
| |
| | |
| [Test] is usually normal among patients with [disease name].
| |
| | |
| OR
| |
| | |
| Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].
| |
| | |
| OR
| |
| | |
| There are no diagnostic laboratory findings associated with [disease name].
| |
| | |
| ===Electrocardiogram===
| |
| There are no ECG findings associated with [disease name].
| |
| | |
| OR
| |
| | |
| An ECG may be helpful in the diagnosis of [disease name]. Findings on an ECG suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
| |
| | |
| ===X-ray===
| |
| There are no x-ray findings associated with [disease name].
| |
| | |
| OR
| |
| | |
| An x-ray may be helpful in the diagnosis of [disease name]. Findings on an x-ray suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
| |
| | |
| OR
| |
| | |
| There are no x-ray findings associated with [disease name]. However, an x-ray may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
| |
| | |
| ===Echocardiography or Ultrasound===
| |
| There are no echocardiography/ultrasound findings associated with [disease name].
| |
| | |
| OR
| |
| | |
| Echocardiography/ultrasound may be helpful in the diagnosis of [disease name]. Findings on an echocardiography/ultrasound suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3]. | |
| | |
| OR
| |
| | |
| There are no echocardiography/ultrasound findings associated with [disease name]. However, an echocardiography/ultrasound may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
| |
| | |
| ===CT scan===
| |
| There are no CT scan findings associated with [disease name].
| |
| | |
| OR
| |
| | |
| [Location] CT scan may be helpful in the diagnosis of [disease name]. Findings on CT scan suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
| |
| | |
| OR
| |
| | |
| There are no CT scan findings associated with [disease name]. However, a CT scan may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
| |
| | |
| ===MRI===
| |
| There are no MRI findings associated with [disease name].
| |
| | |
| OR
| |
| | |
| [Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
| |
| | |
| OR
| |
| | |
| There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].
| |
| | |
| ===Other Imaging Findings===
| |
| There are no other imaging findings associated with [disease name].
| |
| | |
| OR
| |
| | |
| [Imaging modality] may be helpful in the diagnosis of [disease name]. Findings on an [imaging modality] suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
| |
| | |
| ===Other Diagnostic Studies===
| |
| There are no other diagnostic studies associated with [disease name].
| |
| | |
| OR
| |
| | |
| [Diagnostic study] may be helpful in the diagnosis of [disease name]. Findings suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].
| |
| | |
| OR
| |
| | |
| Other diagnostic studies for [disease name] include [diagnostic study 1], which demonstrates [finding 1], [finding 2], and [finding 3], and [diagnostic study 2], which demonstrates [finding 1], [finding 2], and [finding 3].
| |
|
| |
|
| ==Treatment== | | ==Treatment== |
| ===Medical Therapy===
| | [[Immune Thrombocytopenia medical therapy|Medical Therapy]] | [[Immune Thrombocytopenia interventions|Interventions]] | [[Immune Thrombocytopenia surgery|Surgery]] | [[Immune Thrombocytopenia primary prevention|Primary Prevention]] | [[Immune Thrombocytopenia secondary prevention|Secondary Prevention]] | [[Immune Thrombocytopenia cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Immune Thrombocytopenia future or investigational therapies|Future or Investigational Therapies]] |
| There is no treatment for [disease name]; the mainstay of therapy is supportive care.
| |
| | |
| OR
| |
| | |
| Supportive therapy for [disease name] includes [therapy 1], [therapy 2], and [therapy 3].
| |
| | |
| OR
| |
| | |
| The majority of cases of [disease name] are self-limited and require only supportive care.
| |
| | |
| OR
| |
| | |
| [Disease name] is a medical emergency and requires prompt treatment.
| |
| | |
| OR
| |
| | |
| The mainstay of treatment for [disease name] is [therapy].
| |
| | |
| OR
| |
|
| |
| The optimal therapy for [malignancy name] depends on the stage at diagnosis.
| |
| | |
| OR
| |
| | |
| [Therapy] is recommended among all patients who develop [disease name].
| |
| | |
| OR
| |
| | |
| Pharmacologic medical therapy is recommended among patients with [disease subclass 1], [disease subclass 2], and [disease subclass 3].
| |
| | |
| OR
| |
| | |
| Pharmacologic medical therapies for [disease name] include (either) [therapy 1], [therapy 2], and/or [therapy 3].
| |
| | |
| OR
| |
| | |
| Empiric therapy for [disease name] depends on [disease factor 1] and [disease factor 2].
| |
| | |
| OR
| |
| | |
| Patients with [disease subclass 1] are treated with [therapy 1], whereas patients with [disease subclass 2] are treated with [therapy 2].
| |
| | |
| ===Surgery===
| |
| Surgical intervention is not recommended for the management of [disease name].
| |
| | |
| OR
| |
| | |
| Surgery is not the first-line treatment option for patients with [disease name]. Surgery is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
| |
| | |
| OR
| |
| | |
| The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
| |
| | |
| OR
| |
| | |
| The feasibility of surgery depends on the stage of [malignancy] at diagnosis.
| |
| | |
| OR
| |
| | |
| Surgery is the mainstay of treatment for [disease or malignancy].
| |
| | |
| ===Primary Prevention===
| |
| There are no established measures for the primary prevention of [disease name].
| |
| | |
| OR
| |
| | |
| There are no available vaccines against [disease name].
| |
| | |
| OR
| |
| | |
| Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].
| |
| | |
| OR
| |
| | |
| [Vaccine name] vaccine is recommended for [patient population] to prevent [disease name]. Other primary prevention strategies include [strategy 1], [strategy 2], and [strategy 3].
| |
| | |
| ===Secondary Prevention===
| |
| There are no established measures for the secondary prevention of [disease name].
| |
| | |
| OR
| |
| | |
| Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
| |
| | |
| ==References==
| |
| {{reflist|2}}
| |
| | |
| {{WikiDoc Help Menu}}
| |
| {{WikiDoc Sources}}
| |
| | |
|
| |
|
| ==Case Studies== | | ==Case Studies== |
| [[Xyz case study one|Case #1]] | | [[Immune Thrombocytopenia case study one|Case #1]] |
|
| |
|
| [[Category: (name of the system)]] | | [[Category: Hematology]] |